Capital Advisors Ltd. adds Medidata Solutions Inc (MDSO) to its portfolio

Medidata Solutions Inc (MDSO) : Capital Advisors Ltd. added new position in Medidata Solutions Inc during the most recent quarter end. The investment management firm now holds 500 shares of Medidata Solutions Inc which is valued at $24,850 , the company said in a statement filed on Oct 14, 2016 with the SEC.Medidata Solutions Inc makes up approximately 0.01% of Capital Advisors Ltd.’s portfolio.

Other Hedge Funds, Including , Creative Planning reduced its stake in MDSO by selling 30 shares or 37.5% in the most recent quarter. The Hedge Fund company now holds 50 shares of MDSO which is valued at $2,735. Cutler Group Lp added MDSO to its portfolio by purchasing 2,441 company shares during the most recent quarter which is valued at $137,648. Medidata Solutions Inc makes up approx 0.01% of Cutler Group Lp’s portfolio. Simplex Trading added MDSO to its portfolio by purchasing 1,662 company shares during the most recent quarter which is valued at $92,756. Medidata Solutions Inc makes up approx 0.01% of Simplex Trading’s portfolio.Bnp Paribas Arbitrage Sa reduced its stake in MDSO by selling 9,393 shares or 52.65% in the most recent quarter. The Hedge Fund company now holds 8,448 shares of MDSO which is valued at $475,707.

Medidata Solutions Inc closed down -2.62 points or -5.01% at $49.7 with 9,56,197 shares getting traded on Friday. Post opening the session at $52.56, the shares hit an intraday low of $49.68 and an intraday high of $52.92 and the price fluctuated in this range throughout the day.Shares ended Friday session in Red.

On the company’s financial health, Medidata Solutions Inc reported $0.24 EPS for the quarter, beating the analyst consensus estimate by $ 0.01 according to the earnings call on Jul 20, 2016. Analyst had a consensus of $0.23. The company had revenue of $114.60 million for the quarter, compared to analysts expectations of $112.38 million. The company’s revenue was up 16.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.22 EPS.

Many Wall Street Analysts have commented on Medidata Solutions Inc. Medidata Solutions Inc was Downgraded by Wells Fargo to ” Market Perform” on Jul 21, 2016.

Medidata Solutions Inc. (Medidata) provides cloud-based solutions for life sciences. The Company’s solutions are Medidata Rave an electronic data capture (EDC) and clinical data management system (CDMS) solution; Medidata CTMS a clinical trial management solution; Medidata Designer a protocol design tool; Medidata Insights which offer clinical business analytics and metrics; Medidata Balance a randomization and trial supply management solution; Medidata Patient Cloud an electronic patient-reported outcome (ePRO) application; Medidata Grants Manager which develops and manages trial budgets; Medidata contract research organizations (CRO) Contractor an analytics tool; Medidata SQM a set of cloud-based site quality management dashboards; Medidata Coder a medical coding and synonym management solution; Medidata Safety Gateway which collects and transmits events and related data from the EDC system and Medidata Targeted SDV which implements risk-based monitoring strategies.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Medidata Solutions Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on Medidata Solutions Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.